2019 China Focus@BIO Philadelphia successfully ended, leading a new model of cross-border healthcare cooperation.
The conference organized on June 2 attracted numerous Chinese and American pharmaceutical companies, investment institutions and other well-known consulting institutions attended.
During the conference, panelists discussed cross-border Investment and collaborations in biotech and pharma along with artificial intelligence and digital health. In terms of 1-on-1 meetings, both the capital and project parties have achieved fruitful results. In addition, participant enterprises have carried out comprehensive exhibitions of their products and services.